Adrien Contejean

996 total citations
29 papers, 195 citations indexed

About

Adrien Contejean is a scholar working on Pharmacology, Epidemiology and Hematology. According to data from OpenAlex, Adrien Contejean has authored 29 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Epidemiology and 7 papers in Hematology. Recurrent topics in Adrien Contejean's work include Acute Myeloid Leukemia Research (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Adrien Contejean is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Adrien Contejean collaborates with scholars based in France, United States and Réunion. Adrien Contejean's co-authors include Jean‐Marc Tréluyer, Caroline Charlier, Laurent Chouchana, Étienne Canouï, Solen Kernéis, Didier Bouscary, Frédéric Pène, Francesco Salvo, Éric Grignano and Élie Azoulay and has published in prestigious journals such as Blood, Journal of Antimicrobial Chemotherapy and British Journal of Clinical Pharmacology.

In The Last Decade

Adrien Contejean

25 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrien Contejean France 8 67 51 46 35 34 29 195
Yin Su United States 8 83 1.2× 60 1.2× 32 0.7× 24 0.7× 21 0.6× 24 230
Lobna Shalaby Egypt 10 93 1.4× 130 2.5× 45 1.0× 23 0.7× 22 0.6× 30 278
Marta Romanengo Italy 8 85 1.3× 81 1.6× 42 0.9× 24 0.7× 23 0.7× 17 233
Matthieu Legrand France 7 162 2.4× 139 2.7× 28 0.6× 20 0.6× 52 1.5× 12 319
Anke H. W. Bruns Netherlands 10 251 3.7× 40 0.8× 76 1.7× 27 0.8× 57 1.7× 26 397
Elizabeth Dodds‐Ashley United States 7 106 1.6× 20 0.4× 88 1.9× 21 0.6× 12 0.4× 9 198
Sabrina Beltramini Italy 9 60 0.9× 50 1.0× 132 2.9× 21 0.6× 33 1.0× 18 299
Noa Zemer‐Wassercug Israel 10 101 1.5× 24 0.5× 133 2.9× 54 1.5× 39 1.1× 10 389
Eleni Massa Greece 8 98 1.5× 23 0.5× 24 0.5× 50 1.4× 26 0.8× 17 189
Vincent Foissaud France 9 24 0.4× 23 0.5× 66 1.4× 11 0.3× 14 0.4× 33 211

Countries citing papers authored by Adrien Contejean

Since Specialization
Citations

This map shows the geographic impact of Adrien Contejean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Contejean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Contejean more than expected).

Fields of papers citing papers by Adrien Contejean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrien Contejean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Contejean. The network helps show where Adrien Contejean may publish in the future.

Co-authorship network of co-authors of Adrien Contejean

This figure shows the co-authorship network connecting the top 25 collaborators of Adrien Contejean. A scholar is included among the top collaborators of Adrien Contejean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrien Contejean. Adrien Contejean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Contejean, Adrien, Nabil Gastli, Hélène Poupet, et al.. (2024). Endogenous endophthalmitis: New insights from a 12-year cohort study. International Journal of Infectious Diseases. 146. 107116–107116. 3 indexed citations
2.
Pagès, Arnaud, Rudy Birsen, Adrien Contejean, et al.. (2024). Venetoclax–proteasome inhibitor–dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. Blood Advances. 9(4). 793–796. 2 indexed citations
3.
Tavernier, Emmanuelle, Jérôme Cornillon, Martin Carré, et al.. (2024). Azacitidine and Venetoclax As a Salvage Therapy for Relapse after Allogeneic Transplantation for Acute Myeloid Leukemia : A Multicentric Study from French Auraml Group. Blood. 144(Supplement 1). 1518–1518. 2 indexed citations
4.
5.
Maillard, Alexis, S. Siméon, Adrien Contejean, et al.. (2024). Effectiveness and safety of cefazolin versus cloxacillin in endocarditis due to methicillin-susceptible Staphylococcus spp.: a multicenter propensity weighted cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 43(8). 1569–1577. 2 indexed citations
6.
7.
8.
9.
Pavèse, Patricia, P. Lesprit, Mylène Maillet, et al.. (2023). Survey on infectious disease telephone hotlines in primary care: General practitioners’ satisfaction and compliance with advice. Infectious Diseases Now. 53(8). 104775–104775.
10.
Contejean, Adrien, Marianne Leruez‐Ville, Jean‐Marc Tréluyer, et al.. (2023). Assessing the risk of adverse pregnancy outcomes and birth defects reporting in women exposed to ganciclovir or valganciclovir during pregnancy: a pharmacovigilance study. Journal of Antimicrobial Chemotherapy. 78(5). 1265–1269. 12 indexed citations
11.
Beuvon, Frédéric, Lise Willems, Éric Grignano, et al.. (2023). Management of Gastro-Intestinal Toxicity of the Pi3 Kinase Inhibitor: Optimizing Future Dosing Strategies. Cancers. 15(8). 2279–2279. 1 indexed citations
12.
Contejean, Adrien, Alexis Maillard, Étienne Canouï, et al.. (2023). Advances in antibacterial treatment of adults with high-risk febrile neutropenia. Journal of Antimicrobial Chemotherapy. 78(9). 2109–2120. 9 indexed citations
13.
Contejean, Adrien, Salam Abbara, Sophie Alviset, et al.. (2022). Antimicrobial stewardship in high-risk febrile neutropenia patients. Antimicrobial Resistance and Infection Control. 11(1). 52–52. 23 indexed citations
14.
Contejean, Adrien, et al.. (2022). Association study between herpes zoster reporting and mRNA COVID‐19 vaccines (BNT162b2 and mRNA‐1273). British Journal of Clinical Pharmacology. 88(7). 3529–3534. 20 indexed citations
15.
Contejean, Adrien, Étienne Canouï, Jacques Fourgeaud, et al.. (2021). Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers of a French University Hospital in Paris, France. Open Forum Infectious Diseases. 8(3). ofab054–ofab054. 5 indexed citations
16.
Contejean, Adrien, Fréderique Larousserie, Didier Bouscary, et al.. (2020). A colonic mass revealing a disseminated crystal storing histiocytosis secondary to indolent multiple myeloma: a case report with literature review. BMC Gastroenterology. 20(1). 239–239. 3 indexed citations
17.
Contejean, Adrien, Sihem Benaboud, Jean‐Marc Tréluyer, et al.. (2020). A meropenem pharmacokinetics model in patients with haematological malignancies. Journal of Antimicrobial Chemotherapy. 75(10). 2960–2968. 7 indexed citations
18.
Boilève, Alice, Adrien Contejean, Élise Sourdeau, et al.. (2019). Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?. Blood Cells Molecules and Diseases. 81. 102392–102392.
19.
Contejean, Adrien, Fabrice Bruneel, Antoine Rabbat, et al.. (2016). Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Ghent University Academic Bibliography (Ghent University). 2 indexed citations
20.
Contejean, Adrien, Virginie Lemiale, Matthieu Resche‐Rigon, et al.. (2016). Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (Grrr-OH) study. Annals of Intensive Care. 6(1). 102–102. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yin Su Breakdown of academic impact, for papers by Lobna Shalaby Breakdown of academic impact, for papers by Marta Romanengo Breakdown of academic impact, for papers by Matthieu Legrand Breakdown of academic impact, for papers by Anke H. W. Bruns Breakdown of academic impact, for papers by Elizabeth Dodds‐Ashley Breakdown of academic impact, for papers by Sabrina Beltramini Breakdown of academic impact, for papers by Noa Zemer‐Wassercug Breakdown of academic impact, for papers by Eleni Massa Breakdown of academic impact, for papers by Vincent Foissaud
Rankless by CCL
2026